been measured in the joint fluid. The range of white cell count and inhibitors was the same in all 4 groups, while the enzyme output varied substantially from low levels in the spondyloarthropathies to very high levels in the septic joints. The higher the erosive potential of the disease, therefore, the more disadvantageous is the inhibitor/enzyme ratio. It is also pointed out that cartilage has physiochemical properties which facilitate and enhance polymorph enzyme output while severely curtailing the activity of the inhibitors. The observation that synovial fluid is inhibitory in vitro may therefore bear little relationship to the situation at the cartilage surface in vivo.
The role of granulocyte neutral proteases and their relationship with their inhibitors in synovial fluid is still a matter of some controversy. In vitro, synovial fluid has an excess of inhibitors1 2 (mainly a1-antitrypsin (a1AT) and a2-macroglobulin (a2MG)) over enzymes, yet there is no doubt that inflamed joints contain both macrophages and, in the fluid itself, very large numbers of polymorphonuclear leucocytes. These are capable of secreting into the extracellular medium a wide variety of neutral proteases which have been shown in vitro to be highly destructive to a variety of tissues, including cartilage. [3] [4] [5] enzyme secretion. The septic arthritic group showed the extreme levels which could be reached by polymorph enzyme secretion without equivalent rises in inflammatory parameters. That this was more dependent on polymorph activity than numbers is shown in Fig. 3 , where the 3-gluc level per 1000 polymorphs is tabulated. The mean is significantly different in each group. By comparing the 3 groups it is clear that high complement consumption i.e., low CH50 levels-was accompanied by increased levels of enzyme secretion and vice versa. It is reasonable to deduce from this that the presence of large complexes of IgG in the joint fluid was directly influencing both parameters, since Henson"2 has shown that the bigger the complex the more f3-gluc is secreted during phagocytosis.
In summary, therefore, the inflammatory parameters in each group remained the same while the enzyme secretion was highly variable. The inflammatory response was clearly a systemic manifestation, while the enzyme production and complement consumption were local events related only to a single joint. The 2 sets of parameters appeared to be entirely independent of each other. The relative activities of these 2 observations-that is, inflammatory response and enzyme production-can be expressed in each individual joint as a ratio. The results are shown in Table 3 . This ratio is significantly different in each of the 4 groups, and the higher ratios are associated with the increased potential destructiveness of the disease process.
Discussion
The 4 types of arthropathies studied in this paper cover the full range of erosive potential. Spondyloarthropathies are generally (although not invariably) nonerosive. Gold and penicillamine are usually considered to modify the erosive potential of rheumatoid disease, and septic arthropathies are highly destructive in a short space of time. The polymorph proteolytic enzyme output, as measured by f3-gluc, is low in the spondyloarthritic group and extremely high in the septic group. The 2 rheumatoid groups are in between. In spite of this rise in enzyme output the inflammatory response, as measured by the white cell count, a,AT and a2MG, is almost the same in all 4 groups, and the a2MG is in fact surprisingly low in the rheumatoid groups compared with the others. The small numbers of paired samples available show that this low level of a2MG is also seen in some rheumatoid sera. Dingle' has demonstrated cathepsin-D in high concentration in an area of pannus-covered erosion in human rheumatoid cartilage, and suggested that fluid-based inhibitors could have little effect on such an environment. He also pointed out that there were 3 main sources of enzymes capable of degrading cartilage. These were the synovium and associated pannus, the chondrocytes themselves-whose activity appeared to be related to the presence of a synovial catabolic factor-and the synovial fluid. Like Hadler he considered that fluid-based enzymes were unlikely to be important because of the high fluid inhibitor concentration.
It is a common observation during a surgical operation to see areas of cartilage eroded at a considerable distance from the leading edge of the pannus. This would suggest that other mechanisms apart from synovium or pannus-based products are likely to be responsible, and this in tum suggests that fluid-based mechanisms may after all be important. There are several reasons why bare cartilage surface, as opposed to that covered by pannus, should be considered as a microenvironment with its own special properties where proteases and inhibitors are concerned. These are discussed below.
Henson" showed that, although polymorphs release lysosomal enzymes in response to a number of stimuli, by far the most powerful stimulus is the presence of immune complexes or aggregates attached to solid surfaces. Enzyme release in this situation is highly specific and does not require cell destruction. He found that only 1/15th of the amount of immune complex is required to stimulate a given amount of f-gluc when it is attached to a solid surface in contrast to when the material is floating freely in the medium. Immune complexes, therefore, attached to the surface of the cartilage are a highly potent stimulant to local enzyme production and would ensure a much higher enzyme output in the immediate vicinity of the cartilage than would be seen in the fluid itself. There is no doubt that rheumatoid cartilage is extensively covered with immune complexes. In a study of biopsy specimens from cartilage surfaces has shown that the diffusion of molecules into cartilage depends on size as well as charge, and considers that 60 000 is the upper limit for cartilage penetration. a,AT has a molecular weight of 60 000 and is strongly negatively charged. a2MG has a molecular weight of 900 000 and is also strongly negatively charged. In addition to exclusion by size, therefore, there is an electrostatic repulsion between cartilage and protease inhibitors which may be strong enough to prevent the inhibitors from even approaching the cartilage surface closely. Ugai et al. 6 have shown in vitro that polymorphs could penetrate several cell diameters below the articular surface-although they have not found this in rheumatoid joints themselves. In such an environment the cells would be virtually immune from the effect of protease inhibitors.
Thirdly, James and Cohen"7 have shown that 2 possible reactions can take place between a,AT and elastase. The first of these involves the formation of a stable complex in which the elastase is inhibited by the a,AT, but they have also observed that elastase can hydrolyse a,AT, inactivating the latter but leaving the enzyme still active. Even at high inhibitor excess both reactions take place equally, and 2 molecules of a,AT are required to inactivate 1 molecule of elastase.
The fourth disadvantage for the inhibitors is the relative inability for a2MG to penetrate the synovial membrane and enter the joint fluid. Although it has been shown that it can be produced by local macrophages,'8 the serum/synovial fluid ratios reported here suggest that systemic production-that is, in the liver-is by far the most important contributor. The importance of a,MG can be surmised from the work of Ekerot.'0 He has shown that it is almost entirely complexed in the joint fluid, whereas a,AT is almost completely in the free state, It is possible, therefore, that a,AT and a,MG work in conjunction to some extent, the former acting as a carrier temporarily inactivating the protease before transferring it to a2MG for permanent inactivation and disposal. Ohlsson 
